GLAXO's ZOFRAN (ONDANSETRON) APPROVED FOR PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING WITH "1-B" RATING AFTER 27-MONTH REVIEW AT FDA